Motley Fool Australia

Zelira Therapeutics Ltd (ASX: ZLD) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover
As at

Fundamental Company Figures

Data provided by Morningstar.
Market Cap $106.68 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 1.19 billion
Earnings per share -0.008
Dividend per share N/A
Year To Date Return 50.91%
Earnings Yield N/A
Franking N/A

Zelira Therapeutics Ltd (ASX: ZLD) Latest News

medical marijuana, cannabis, pot, drug, medical

THC Global share price surges 11% higher on cannabis production update

More »

medical marijuana, cannabis, pot, drug, medical

Why this ASX cannabis share jumped 7.5% higher today

More »

ASX marijuana shares

Should you still be invested in ASX marijuana shares?

More »

ASX cannabis shares have started the year on a high

More »

child in a superman outfit

These 3 ASX small caps are pushing higher today

More »

Medical Cannabis

Canada legalises recreational cannabis use

More »

Why these small cap shares are on the rise today

More »

Cartoon Bang

Why these 4 ASX shares have started the week with a bang

More »

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

About Zelira Therapeutics Ltd (ASX: ZLD)

Zelira Therapeutics Ltd (ASX: ZLD) is a leading global therapeutic medicinal cannabis company with access to the world’s fastest growing cannabis markets. Formerly Zelda Therapeutics, Zelira owns a portfolio of proprietary products and a pipeline of candidates undergoing clinical development.

The company focus is on developing branded cannabis products for the treatment of a variety of medical conditions, including insomnia, autism and opioid reduction. Zelira has launched two proprietary formulations under the HOPE brand for autism in multiple US-states with plans to expand into global markets in 2020. 

Share Price History

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
02 Dec 2020 $0.09 $0.01 12.35% 8,548,912 $0.09 $0.09 $0.09
01 Dec 2020 $0.08 $0.00 0.00% 2,323,500 $0.09 $0.09 $0.08
30 Nov 2020 $0.08 $0.01 12.99% 5,882,591 $0.08 $0.09 $0.08
27 Nov 2020 $0.08 $0.00 0.00% 918,932 $0.08 $0.08 $0.08
26 Nov 2020 $0.08 $0.00 0.00% 1,410,466 $0.08 $0.08 $0.08
25 Nov 2020 $0.08 $0.00 0.00% 3,653,567 $0.08 $0.08 $0.08
24 Nov 2020 $0.08 $0.00 0.00% 4,877,474 $0.08 $0.08 $0.08
23 Nov 2020 $0.08 $0.01 14.71% 5,118,523 $0.07 $0.08 $0.07
20 Nov 2020 $0.07 $0.00 0.00% 1,451,771 $0.07 $0.07 $0.07
19 Nov 2020 $0.07 $0.00 0.00% 1,689,999 $0.07 $0.07 $0.07
18 Nov 2020 $0.07 $0.00 0.00% 1,161,818 $0.07 $0.07 $0.07
17 Nov 2020 $0.07 $0.00 0.00% 3,203,831 $0.07 $0.07 $0.07
16 Nov 2020 $0.07 $0.00 0.00% 321,899 $0.07 $0.07 $0.07
13 Nov 2020 $0.07 $0.00 0.00% 1,761,319 $0.07 $0.07 $0.07
12 Nov 2020 $0.07 $0.00 0.00% 3,063,596 $0.07 $0.07 $0.07
11 Nov 2020 $0.07 $0.00 0.00% 3,469,540 $0.07 $0.07 $0.07
10 Nov 2020 $0.07 $0.00 0.00% 2,391,635 $0.07 $0.08 $0.07
09 Nov 2020 $0.07 $0.00 0.00% 3,178,206 $0.07 $0.08 $0.07
06 Nov 2020 $0.07 $0.00 0.00% 1,088,282 $0.07 $0.07 $0.07
05 Nov 2020 $0.07 $0.00 0.00% 1,272,760 $0.07 $0.08 $0.07
04 Nov 2020 $0.07 $0.00 0.00% 866,524 $0.08 $0.08 $0.07
03 Nov 2020 $0.08 $0.00 0.00% 1,092,106 $0.07 $0.08 $0.07
Show more

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
11 Aug 2020 Richard Hopkins Issued 1 $50,000
11 Aug 2020 Oludare Odumosu Issued 25 $1,300,000
02 Jan 2020 Osagie Imasogie Issued 16 $902,718
02 Jan 2020 Osagie Imasogie Issued 104 $5,867,817
02 Jan 2020 Lisa Gray Issued 16 $902,718
02 Jan 2020 Lisa Gray Issued 104 $5,867,817
02 Jan 2020 Oludare Odumosu Issued 35 $1,966,532
02 Jan 2020 Oludare Odumosu Issued 5 $302,536
23 Dec 2019 Jason Peterson Issued 12 $1,250
23 Dec 2019 Harry Karelis Issued 12 $1,250
23 Dec 2019 Richard Hopkins Issued 12 $1,250
Show more


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Mr Harry Karelis Executive Director,Executive Deputy Chairman Nov 2016
Dr Richard Miles Hopkins Managing Director Jul 2018
Mr Jason William Peterson Non-Executive Director Nov 2016
Dr Oludare Odumosu Non-Executive Director Dec 2019
Mr Osagie Imasogie Non-Executive Chairman,Non-Executive Director Dec 2019
Ms Lisa Gray Non-Executive Director Dec 2019
Mr Timothy (Tim) Ryan Slate Company Secretary Dec 2016
Timothy (Tim) Ryan Slate Company Secretary
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
Sunset Capital Management Pty Ltd 55,413,617 4.85%
Gemelli Nominees Pty Ltd 49,587,680 4.34%
Mara Gordon 44,142,326 3.86%
Mal Washer Nominees Pty Ltd 35,198,688 3.08%
Capricorn Investment Partners (Nominees) Pty Ltd 17,577,883 1.54%
Citicorp Nominees Pty Limited 16,756,434 1.47%
HSBC Custody Nominees (Australia) Limited 16,699,968 1.46%
Mr Torsten M Geers 16,413,065 1.44%
Mr Zoltan Kerekes 16,413,065 1.44%
Ms Lisa Gray 16,413,065 1.44%
Osagie Imasogie 16,413,065 1.44%
Sharri J Rochlin 16,413,065 1.44%
Ubs Nominees Pty Ltd 15,800,000 1.38%
JP Morgan Nominees Australia Pty Limited 13,930,688 1.22%
Mera I LLC \C 13,879,566 1.22%
Mr Amit Gupta 11,529,999 1.01%
Celtic Capital Pty Ltd 11,200,000 0.98%
Copper Lake Holdings Limited 10,075,203 0.88%
Mr Alan Trounson 10,075,203 0.88%
Xena Advisors Llc 8,888,889 0.78%
Show more